GlassScriptPhysician profile
Margaret M Gold
NPI 1831178169
$852.50
in general payments reported to CMS, 2019-2025
21 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Integrative Medicine provider received nationally (typical 2025 total: $57.65).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $29.52 · 2024: $454 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $101.00 | 2024-2025 | |
| Gilead Sciences, INC. | $75.37 | 2024-2025 | |
| Exact Sciences Corporation | $63.91 | 2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $62.71 | 2024 | Mounjaro |
| Astellas Pharma US INC | $55.75 | 2024-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $51.00 | 2024-2025 | Farxiga |
| Abiomed | $48.14 | 2025 | |
| Novartis Pharmaceuticals Corporation | $45.17 | 2024 | |
| Almatica Pharma LLC | $42.04 | 2025 | Loreev Xr |
| Sanofi Pasteur INC. | $41.06 | 2024-2025 | |
| Glaxosmithkline, LLC. | $39.83 | 2024-2025 | Arexvy, Trelegy Ellipta |
| Medtronic, INC. | $29.52 | 2023 | Linq II |
| Seqirus USA INC | $25.91 | 2024 | Fluad, Flucelvax |
| Janssen Pharmaceuticals, INC | $25.50 | 2024 | Spravato |
| Amgen INC. | $24.44 | 2025 | Prolia, Evenity |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $24.40 | 2024 | (Ck7) Extended Holter |
| Inspire Medical Systems, INC. | $22.31 | 2025 | Inspire |
| Hologic Sales and Service, LLC | $22.24 | 2024 | Aptima |
| Viiv Healthcare Company | $18.20 | 2025 | Apretude |
| Optinose US, INC. | $17.69 | 2024 | |
| Cranial Technologies, INC | $16.31 | 2025 | Doc Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Gold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.